Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG

170 Annual Financial Statement Konzern-Jahresabschluss
9. Segment reporting
The group’s segmentation refers to the internal organization and reporting structure.
The segmentation was done in accordance with IFRS 8.11-.13 and hence the operative segments Medical
Technology and Pharma were defined. Medical Technology sales are primarily generated by fibers
and laser probes. It comprises of the product groups laser probes and fibers with more than 30 different
light conducting systems on fiber optic basis. The majority of these products are disposables for medical
purposes. The biolitec group’s lasers are mainly diode lasers, which due to the method of construction
are characterized by their small size and low maintenance requirements. The production of biolitec’s
laser probes and optical fibers features a high level of vertical integration and is located at the groups’
subsidiaries in Bonn / Germany, in the USA and in Latvia. In the USA (complete assembly), Malaysia (preassembly)
as well as Bonn (final assembly) the level of automation in production is low.
The Pharma segment comprises of production, development and distribution of pharmaceutical substances.